Corrigendum to “Intranasal Administration of the Growth-Compromised HSV-2 Vector ΔRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice”

Molecular Therapy - United States
doi 10.1038/sj.mt.6300211

Related search